Inogen, Inc. is a medical technology company, which engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company is headquartered in Goleta, California and currently employs 753 full-time employees. The company went IPO on 2014-02-14. The company supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One and Inogen Rove systems reduce the patient’s reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen. Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5, Inogen Rove 4, and Inogen Rove 6, consisting of a front-end mobile application for use by long-term oxygen therapy users. The company offers Simeox, which is an airway clearance device.
Mr. Kevin Smith es el President de Inogen Inc, se unió a la empresa desde 2023.
¿Qué tal es el rendimiento del precio de la acción INGN?
El precio actual de INGN es de $6.31, ha disminuido un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Inogen Inc?
Inogen Inc pertenece a la industria Health Care y el sector es Health Care
¿Cuál es la capitalización bursátil de Inogen Inc?
La capitalización bursátil actual de Inogen Inc es $171.8M
¿Es Inogen Inc una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 5 analistas han realizado calificaciones de análisis para Inogen Inc, incluyendo 2 fuerte compra, 5 compra, 1 mantener, 0 venta, y 2 fuerte venta